Literature DB >> 22437422

Fate of combat nerve injury.

Michael J Beltran1, Travis C Burns, Tobin T Eckel, Benjamin K Potter, Joseph C Wenke, Joseph R Hsu.   

Abstract

OBJECTIVE: Assess a cohort of combat-related type III open tibia fractures with peripheral nerve injury to determine the injury mechanism and likelihood for recovery or improvement in nerve function.
DESIGN: Retrospective study.
SETTING: Three military medical centers. PATIENTS AND PARTICIPANTS: Out of a study cohort of 213 type III open tibia fractures, 32 fractures (in 32 patients) with a total of 43 peripheral nerve injuries (peroneal or tibial) distal to the popliteal fossa met inclusion criteria and were available for follow-up at an average of 20 months (range, 2-48 months). MAIN OUTCOME MEASUREMENTS: Clinical assessment of motor and sensory nerve improvement.
RESULTS: There was a 22% incidence of peripheral nerve injury in the study cohort. At an average follow-up of 20 months (range, 2-48 months), 89% of injured motor nerves were functional, whereas the injured sensory nerves had function in 93%. Fifty percent and 27% of motor and sensory injuries demonstrated improvement, respectively (P = 0.043). With the numbers available, there was no difference in motor or sensory improvement based on mechanism of injury, fracture severity or location, soft tissue injury, or specific nerve injured. In the subset of patients with an initially impaired sensory examination, full improvement was related to fracture location (P = 0.0164).
CONCLUSIONS: Type III open tibia fractures sustained in combat are associated with a 22% incidence of peripheral nerve injury, and the majority are due to multiple projectile penetrating injury. Despite the severe nature of these injuries, the vast majority of patients had a functional nerve status by an average of 2-year follow-up. Based on these findings, discussions regarding limb salvage and amputation should not be overly influenced by the patient's peripheral nerve status. LEVEL OF EVIDENCE: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2012        PMID: 22437422     DOI: 10.1097/BOT.0b013e31823f000e

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  4 in total

1.  4-Aminopyridine: A Single-Dose Diagnostic Agent to Differentiate Axonal Continuity in Nerve Injuries.

Authors:  Anagha A Gurjar; Kristen M Manto; Juan A Estrada; Marc Kaufman; Dongxiao Sun; M A Hassan Talukder; John C Elfar
Journal:  Mil Med       Date:  2021-01-25       Impact factor: 1.437

Review 2.  Engineering skeletal muscle: Building complexity to achieve functionality.

Authors:  Eszter Mihaly; Dallas E Altamirano; Sami Tuffaha; Warren Grayson
Journal:  Semin Cell Dev Biol       Date:  2021-05-11       Impact factor: 7.499

3.  SUR1, newly expressed in astrocytes, mediates neuropathic pain in a mouse model of peripheral nerve injury.

Authors:  Orest Tsymbalyuk; Volodymyr Gerzanich; Aaida Mumtaz; Sanketh Andhavarapu; Svetlana Ivanova; Tapas K Makar; Charles A Sansur; Asaf Keller; Yumiko Nakamura; Joseph Bryan; J Marc Simard
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

4.  Electrical stimulation of human neural stem cells via conductive polymer nerve guides enhances peripheral nerve recovery.

Authors:  Shang Song; Kelly W McConnell; Danielle Amores; Alexa Levinson; Hannes Vogel; Marco Quarta; Thomas A Rando; Paul M George
Journal:  Biomaterials       Date:  2021-06-23       Impact factor: 15.304

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.